Global Survivorship Care Software Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Global Survivorship Care Software Market Segmentation, By Component (Software Solutions, Services), Deployment Mode (Cloud-Based, On-Premises, Hybrid), Application (Survivorship Care Plan Generation & Management, Long-term Follow-up & Surveillance Scheduling, Late Effects Monitoring & Management, Patient-Reported Outcome Collection, Psychosocial Support & Mental Health Coordination), End User (Hospitals & Cancer Centers, Oncology Clinics & Group Practices, Academic & Research Institutions, Health Systems & Integrated Delivery Networks) — Industry Trends and Forecast to 2033

Survivorship Care Software Market Size

• The global Survivorship Care Software market size was valued at USD 1.8 billion in 2025 and is expected to reach USD 7.6 billion by 2033, at a CAGR of 7% during the forecast period.
• Market growth is primarily driven by the rapidly expanding global cancer survivor population, mandatory accreditation requirements for formal survivorship care planning from bodies such as the Commission on Cancer (CoC) and NAPBC, and increasing recognition of the long-term health management needs of cancer survivors beyond active treatment completion.
• Additionally, growing investments in digital oncology infrastructure, rising adoption of cloud-based care coordination platforms, increasing integration of AI-powered late effects monitoring, expanding telehealth-based survivorship services, and growing payer interest in value-based oncology care models are supporting strong global market expansion.

Survivorship Care Software Market Analysis

• Survivorship Care Software, widely used for generating and managing survivorship care plans (SCPs), scheduling long-term follow-up visits, monitoring treatment-related late effects, collecting patient-reported outcomes (PROs), and coordinating psychosocial support services, enables cancer centers and oncology practices to provide structured, evidence-based care for the growing population of cancer survivors post active treatment.
• The growing demand for survivorship care software is driven by the rapidly increasing global cancer survivor population — with an estimated 18.6 million survivors in the United States alone as of January 2025 — combined with heightened institutional focus on survivorship program accreditation, rising complexity of long-term cancer follow-up care, and the growing need for digital tools to support coordinated, continuous post-treatment management.
• North America dominated the Survivorship Care Software market with a share of 44.67% in 2025, supported by the presence of a mature oncology digital health ecosystem, strong Commission on Cancer accreditation requirements mandating survivorship care plans, high adoption of oncology information systems (OIS) with embedded survivorship modules, and significant investment by leading cancer centers in dedicated survivorship care infrastructure.
• Asia-Pacific is expected to be the fastest-growing region with a cagr of 14.50%, driven by rapidly rising cancer incidence rates, expanding digital health infrastructure across China, India, Japan, and South Korea, growing government investments in national cancer care programs, and increasing awareness among oncology providers of the clinical and operational value of structured survivorship care management platforms.
• The Software Solutions segment dominated the market with a share of 62.50%, due to its critical role in enabling systematic, scalable survivorship care plan generation, follow-up scheduling automation, and EHR-integrated patient monitoring, supported by strong institutional demand from hospital-based cancer programs seeking accreditation compliance and operational efficiency.

Report Scope and Survivorship Care Software Market Segmentation

Survivorship Care Software Market Trends

"Escalating Commission on Cancer accreditation requirements and growing cancer survivor populations are accelerating institutional investment in dedicated survivorship care software platforms"

• Escalating Commission on Cancer (CoC) and National Accreditation Program for Breast Centers (NAPBC) accreditation mandates requiring documented survivorship care plans for all eligible cancer patients are creating significant, non-discretionary demand for specialized survivorship care software across hospital-based and community cancer programs.
• The rapidly growing global cancer survivor population — projected to exceed 22 million in the United States by 2035 and grow significantly across Asia-Pacific and Europe — is expanding the addressable market for long-term survivorship care management software at an accelerating rate.
• Increasing adoption of AI and machine learning within survivorship platforms is enabling proactive identification of late effects, predictive risk scoring for long-term complications, and automated care pathway adjustments based on individual treatment histories, significantly improving clinical outcomes for cancer survivors.
• Growing integration of survivorship care software with electronic health records (EHRs), oncology information systems (OIS), and patient portals is enabling seamless data exchange, reducing documentation burden, and improving care coordination between oncology specialists and primary care providers during the survivorship phase.
• Rising demand for patient-reported outcome (PRO) collection capabilities within survivorship platforms is being driven by payer requirements, value-based care contracts, and clinical trial protocols that require systematic, longitudinal tracking of survivor health status and quality of life metrics.
• Expansion of telehealth-based survivorship clinics, accelerated by the lasting digital health shift following COVID-19, is increasing demand for software platforms that support virtual survivorship care delivery, remote monitoring, and digital care plan communication.
• Growing focus on addressing psychosocial needs, mental health, fertility issues, and sexual health concerns within survivorship programs is expanding the functional scope of survivorship care software, driving demand for comprehensive platforms that integrate mental health coordination and supportive care resources.
• Overall, convergence of regulatory mandates, population growth in the cancer survivor segment, and digital health innovation is transforming survivorship care software into a high-priority institutional investment across oncology programs worldwide.

Survivorship Care Software Market Dynamics

Driver

"Mandatory accreditation requirements for survivorship care planning combined with rapidly expanding cancer survivor populations are driving institutional adoption of dedicated survivorship care software"

• Mandatory survivorship care planning requirements from accreditation bodies including the American College of Surgeons’ Commission on Cancer (CoC), the National Accreditation Program for Breast Centers (NAPBC), and the Quality Oncology Practice Initiative (QOPI) are compelling cancer centers to invest in specialized software solutions that can efficiently generate, manage, and document formal survivorship care plans at scale.
• The United States cancer survivor population reached approximately 18.6 million as of January 2025, with projections indicating growth to over 22 million by 2035, according to the American Cancer Society and National Cancer Institute, creating a rapidly expanding patient base requiring long-term structured survivorship care management supported by dedicated software platforms.
• Globally, improvements in cancer treatment outcomes including advances in immunotherapy, targeted therapies, and early detection technologies are significantly increasing cancer survival rates, directly expanding the population requiring ongoing survivorship care coordination and long-term follow-up management.
• Growing recognition among oncology providers that structured survivorship care programs reduce hospital readmissions, improve detection of late treatment effects, enhance quality of life, and support transition back to primary care is increasing the clinical and financial justification for dedicated survivorship care software investment.
• Expanding value-based care and oncology payment models, including the Centers for Medicare & Medicaid Services’ Enhancing Oncology Model (EOM), are incentivizing cancer programs to demonstrate comprehensive, longitudinal patient management capabilities, further driving adoption of survivorship care software with robust patient tracking and outcome reporting functionality.
• Rising payer interest in survivorship care coordination as a strategy to reduce long-term healthcare costs associated with unmanaged cancer treatment late effects is supporting reimbursement developments that improve the commercial sustainability of survivorship program investments, including software platforms.
• Growing workforce efficiency pressures in oncology, driven by increasing patient volumes and limited specialist availability, are accelerating adoption of software-driven survivorship care plan automation and care coordination tools that reduce documentation burden and improve navigator and clinician productivity.

Restraint/Challenge

"Limited interoperability between survivorship care software and existing EHR systems is creating significant implementation barriers and reducing clinical adoption"

• Limited interoperability between dedicated survivorship care software platforms and existing electronic health record (EHR) and oncology information system (OIS) infrastructure is a significant challenge, creating fragmented clinical workflows, duplicate data entry requirements, and reduced adoption among oncology care teams.
• Complexity and heterogeneity of cancer survivor needs — spanning diverse cancer types, treatment modalities, comorbidities, and psychosocial factors — make it technically challenging to build universally applicable survivorship care software that meets the clinical requirements of all cancer programs and patient populations.
• High implementation and customization costs, combined with lengthy integration timelines for EHR and OIS connectivity, create significant barriers for smaller community oncology practices and resource-constrained cancer centers that lack dedicated IT infrastructure and implementation support capacity.
• Shortage of specialized survivorship care professionals, including advanced practice providers trained in cancer survivorship, limits the clinical capacity needed to fully leverage survivorship care software capabilities, reducing return on investment for institutions that implement these platforms.
• Variability in survivorship care plan completion rates and clinical practice consistency across different care team members and institutions creates implementation challenges, as software adoption alone cannot guarantee meaningful improvements in survivorship care quality without corresponding clinical culture change and training programs.
• Data privacy and security concerns specific to the sensitive, longitudinal nature of cancer survivor health records create compliance requirements that increase software development and deployment complexity, particularly across multi-institutional and cross-border implementations.
• These combined factors create a complex adoption environment requiring software developers to invest heavily in EHR integration, clinical workflow optimization, and flexible customization capabilities to overcome institutional implementation barriers.

Survivorship Care Software Market Scope

The market is segmented on the basis of component, deployment mode, application, and end user.

By Component

On the basis of Component, the global Survivorship Care Software market is segmented into Software Solutions and Services (Implementation, Training & Support, Consulting). The Software Solutions segment dominated the market with the largest revenue share of 62.50% in 2025, driven by strong institutional demand for scalable survivorship care plan generation, automated follow-up scheduling, EHR-integrated patient monitoring, and accreditation-compliant documentation tools across hospital-based cancer programs and academic cancer centers. The growing availability of comprehensive, purpose-built survivorship platforms with modular functionality further supports this segment's dominance.

The Services segment is expected to witness the fastest growth of 13.20% during the forecast period, fueled by increasing institutional complexity in survivorship software implementation, growing demand for clinical workflow optimization consulting, and the need for ongoing training and support programs as cancer centers scale their survivorship care capabilities and integrate platforms with existing EHR and OIS infrastructure.

By Deployment Mode

On the basis of Deployment Mode, the global Survivorship Care Software market is segmented into Cloud-Based, On-Premises, and Hybrid. The Cloud-Based segment dominated the market with a share of 58.00% in 2025, driven by strong adoption across cancer centers seeking lower upfront capital investment, faster implementation timelines, automatic software updates, and scalable multi-site deployment capabilities. Cloud-based platforms offer significant operational advantages for managing survivorship care across distributed care networks, patient portals, and telehealth-enabled follow-up programs.

The Hybrid deployment segment is expected to witness the fastest growth of 14.50% during the forecast period, fueled by increasing demand from large academic medical centers and health systems that require the operational flexibility of cloud-based access combined with the data sovereignty and security control of on-premises infrastructure for managing sensitive, longitudinal cancer survivor health records.

By Application

On the basis of Application, the global Survivorship Care Software market is segmented into Survivorship Care Plan Generation & Management, Long-term Follow-up & Surveillance Scheduling, Late Effects Monitoring & Management, Patient-Reported Outcome (PRO) Collection, and Psychosocial Support & Mental Health Coordination. The Survivorship Care Plan Generation & Management segment dominated the market with a share of 34.00% in 2025, driven by its direct alignment with CoC and NAPBC accreditation requirements, strong clinical prioritization across comprehensive cancer centers, and the operational efficiency gains achieved through automated, treatment-specific SCP generation compared to manual documentation approaches.

The Late Effects Monitoring & Management segment is expected to witness the fastest growth of 15.80% during the forecast period, fueled by growing clinical evidence linking structured monitoring protocols to improved long-term survivor outcomes, increasing payer focus on proactive late effects management to reduce downstream healthcare costs, and rising demand for AI-powered predictive analytics capabilities that enable early identification of cardiotoxicity, neuropathy, and secondary cancer risks in defined survivor populations.

By End User

On the basis of End User, the global Survivorship Care Software market is segmented into Hospitals & Cancer Centers, Oncology Clinics & Group Practices, Academic & Research Institutions, and Health Systems & Integrated Delivery Networks. The Hospitals & Cancer Centers segment dominated the market with a share of 44.67% in 2025, as these institutions face the strongest accreditation-driven mandates for survivorship care plan documentation, manage the largest survivor patient volumes, and have the organizational resources and strategic priority to invest in comprehensive survivorship care software infrastructure.

The Health Systems & Integrated Delivery Networks segment is expected to witness the fastest growth of 13.54% during the forecast period, fueled by the increasing consolidation of oncology care delivery within integrated health system structures, growing demand for enterprise-wide survivorship care management across multiple cancer care sites, and the operational and data analytics advantages of centralized survivorship software platforms deployed across large, multi-site oncology networks.

Survivorship Care Software Market Regional Analysis

• North America dominated the Survivorship Care Software market with the largest revenue share in 2025, supported by mature Commission on Cancer accreditation standards mandating survivorship care plans, the largest global cancer survivor population, strong digital oncology infrastructure, high EHR adoption, and significant presence of leading survivorship care software vendors including Equicare Health, Carevive Systems, and Navigating Cancer. Additionally, increasing investment by National Cancer Institute (NCI)-designated cancer centers in comprehensive survivorship program infrastructure further reinforces the region’s market leadership.
• Cancer centers and health systems across North America place strong institutional emphasis on survivorship program quality, accreditation compliance, value-based care performance, and patient engagement beyond active treatment, driving widespread adoption of dedicated survivorship care software platforms for care plan management, follow-up automation, late effects tracking, and psychosocial care coordination.
• This strong market position is further supported by rising CMS reimbursement developments for chronic care management and principal care management services that can be supported through survivorship software platforms, growing institutional investment in survivorship program navigator roles, and increasing pharmaceutical and payer interest in longitudinal cancer survivor health management as a component of comprehensive oncology care.

U.S. Survivorship Care Software Market Insight

The U.S. Survivorship Care Software market holds a dominant global position, driven by the largest cancer survivor population globally — estimated at 18.6 million as of January 2025 — strong CoC and NAPBC accreditation mandates, advanced digital oncology infrastructure, and high institutional investment in survivorship program development across NCI-designated cancer centers, academic medical centers, and community oncology networks. Increasing integration of survivorship care software with major EHR platforms including Epic and Cerner, growing adoption of AI-powered late effects monitoring, and expanding telehealth-based survivorship clinic models are further strengthening market growth. Additionally, rising CMS focus on value-based oncology care models that reward long-term care coordination is supporting broader institutional adoption of structured survivorship software platforms.

Europe Survivorship Care Software Market Insight

The Europe Survivorship Care Software market is witnessing steady growth, driven by expanding national cancer control programs, increasing recognition of survivorship care as a critical component of comprehensive oncology services, and growing digital health transformation investments across Germany, the United Kingdom, France, and the Netherlands. The European Commission’s Europe’s Beating Cancer Plan, which explicitly identifies survivorship care improvement as a strategic priority, is driving institutional investment in survivorship care infrastructure across European cancer centers. Additionally, growing adoption of structured survivorship care plans in NHS and public health system cancer pathways, increasing demand for EHR-integrated survivorship management tools, and expanding telehealth-based follow-up programs are supporting market expansion.

U.K. Survivorship Care Software Market Insight

The U.K. Survivorship Care Software market is experiencing steady growth, driven by the National Health Service’s active Cancer Programme commitments to improving post-treatment support for cancer survivors, increasing focus on personalised stratified follow-up pathways, and growing adoption of digital tools for managing the rapidly growing cancer survivor population. The NHS Long Term Plan’s emphasis on personalised care and supported self-management in cancer survivorship is accelerating institutional interest in dedicated survivorship care software that enables scalable, structured follow-up coordination and patient engagement beyond active treatment completion.

Germany Survivorship Care Software Market Insight

The Germany Survivorship Care Software market is expected to grow steadily during the forecast period, driven by Germany’s advanced oncology care infrastructure, increasing adoption of digital health tools under the Digital Health Applications (DiGA) framework, and growing recognition of structured survivorship care as a component of high-quality comprehensive cancer care. Strong demand from comprehensive cancer centers (Comprehensive Cancer Centers, CCCs) certified by the German Cancer Aid Foundation, increasing investment in digital oncology platforms, and growing focus on long-term cancer follow-up coordination across integrated care networks are supporting market expansion.

Japan Survivorship Care Software Market Insight

The Japan Survivorship Care Software market is witnessing growing interest, driven by Japan’s aging population, high cancer incidence, and the government’s Comprehensive Cancer Control Program that emphasizes improved survivorship care quality as a national priority. Rising adoption of digital health solutions within Japan’s hospital system, increasing investment in cancer center digitalization, and growing recognition of the clinical value of structured long-term follow-up management for Japan’s expanding cancer survivor population are supporting market development. Additionally, growing interest in AI-powered late effects surveillance and EHR-integrated survivorship care planning tools is further driving market growth.

India Survivorship Care Software Market Insight

The India Survivorship Care Software market is at an early but rapidly developing stage, driven by rising cancer incidence, expanding cancer center infrastructure, and increasing awareness of structured survivorship care as a component of comprehensive oncology services. Government initiatives under the National Cancer Control Programme and the Ayushman Bharat Digital Mission are accelerating digital health adoption across oncology care settings. Growing investments from private hospital networks and international oncology partnerships in comprehensive cancer care programs, combined with increasing demand for affordable cloud-based survivorship software solutions suited to the Indian healthcare context, are creating emerging market opportunities.

Survivorship Care Software Market Share

The Survivorship Care Software industry is primarily led by well-established companies, including:

• Equicare Health Inc. (Canada)
• Carevive Systems (U.S.)
• Navigating Cancer (U.S.)
• Flatiron Health (U.S.)
• Varian Medical Systems / Siemens Healthineers (U.S./Germany)
• MEDITECH (U.S.)
• Epic Systems Corporation (U.S.)
• Cerner Corporation / Oracle Health (U.S.)
• McKesson Corporation (U.S.)
• Allscripts Healthcare Solutions (U.S.)
• Elekta AB (Sweden)
• careMESH (U.S.)

Recent Developments in Global Survivorship Care Software Market

• In April 2026, Black Book Research released its 2026 State of Digital Healthcare in Oncology report, highlighting survivorship care coordination and patient-reported outcome collection as strategic investment priorities for U.S. cancer programs, with survivorship software platforms identified as a key component of the emerging connected digital oncology operating model spanning navigation, analytics, and long-term care management.
• In January 2026, Navigating Cancer announced an expanded partnership with a major U.S. health system to deploy its comprehensive oncology patient engagement and survivorship care platform across 12 cancer care sites, supporting automated survivorship care plan generation, PRO collection, and accreditation-compliant documentation integrated with the health system’s Epic EHR environment.
• In October 2025, Equicare Health released an enhanced version of its EQUICARE CS survivorship care coordination platform, incorporating AI-powered late effects risk stratification, expanded telehealth visit scheduling capabilities, and improved interoperability with major oncology information systems, enabling cancer centers to deliver more proactive, personalized post-treatment survivor management at scale.
• In July 2025, Carevive Systems expanded its oncology-specific care plan platform with new survivorship care modules supporting structured late effects monitoring, personalized wellness recommendations, and EHR-embedded survivorship care plan workflows, targeting large academic cancer centers and community oncology networks seeking accreditation-compliant survivorship program infrastructure.

SKU-75874